-
Phylo’s Biomni Lab to expand the use of AI agents in scientific research at Bayer
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 /PRNewswire/ — Phylo, Inc. announced today a partnership with Bayer to deploy Biomni Lab, Phylo’s agentic AI platform to accelerate scientific research and evaluation. Under the agreement, Phylo will provide Bayer with full access to its agentic… Source: Read More
-
Trinity Acquires Verix, Adding AI-Powered Next-Best-Action and Omnichannel Orchestration to the TrinityEDGE Platform
Verix’s patented Tovana™ platform and its full team join Trinity, extending TrinityEDGE™ from what commercial teams know into what they do next WALTHAM, Mass., Oct. 20, 2026 /PRNewswire/ — Trinity, the leader in integrating human and artificial intelligence for life sciences… Source: Read More
-
Revolutionizing Healthcare: How Open Source AI is Transforming Medical Video Analysis
A New Era for Medical Imaging The landscape of healthcare technology is shifting rapidly, thanks to a breakthrough in open-source artificial intelligence. A recent development has introduced a powerful new model designed specifically to accelerate global progress in medical video AI. By making this technology accessible, researchers and developers are now better equipped to handle…
-
Revolutionizing Medical Research: First Foundation Labs Partners with Microsoft
A New Era for Clinical Discovery The landscape of medical research is undergoing a significant transformation as First Foundation Labs, an initiative founded by the Luma Group, announces a strategic collaboration with Microsoft. By integrating AI-powered clinical and translational reasoning into the Microsoft Discovery platform, this partnership aims to accelerate how researchers approach complex medical…
-
Hoth Therapeutics Leverages OpenAI API to Accelerate Development of Orphan Oncology Program, HT-KIT
NASDAQ: $HOTH Hoth Therapeutics, Inc., a biopharmaceutical company dedicated to patient-focused therapies, recently announced a significant strategic move: the deployment of the OpenAI API to bolster the development of its orphan-designated therapy, HT-KIT. This innovative integration targets rare and aggressive KIT-driven cancers, marking a forward-thinking approach to drug development within the oncology space. AI Integration…
-
Pharos AI and 10x Genomics Join Forces to Advance Cancer Research Through Integrated Technology
NASDAQ: $TXG A significant collaboration has been established between Pharos AI, a leader in artificial intelligence solutions for the life sciences, and 10x Genomics, a pioneer in single cell and spatial biology technologies. This partnership is set to revolutionize how researchers approach complex challenges in oncology by integrating advanced computational power with cutting-edge molecular analysis.…
-
Presentation of topline long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial highlighting new findings from the ATTENTION-AD study evaluating potential benefit of oral once daily blarcamesine (ANAVEX®2-73) in early Alzheimer’s disease.
NASDAQ: $AVXL The presentation of topline long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial marks a significant milestone in the field of Alzheimer’s disease research. This article delves into the latest findings from the ATTENTION-AD trial, shedding light on the efficacy and safety of the investigational treatment over an extended period. With a…
-
RxE2 | Revolutionizes Clinical Trials with Groundbreaking AI-led Technology Platform and Marketplace
Introduction In the world of medical advancements, clinical trials play a crucial role in testing new drugs, treatments, and procedures to ensure their safety and efficacy. However, the traditional approach to conducting clinical trials is often time-consuming, costly, and resource-intensive. Enter RxE2, an innovative technology platform and marketplace that is revolutionizing the way clinical trials…